Movelat Relief (Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid)

Movelat Relief, containing a keratolytic and moisturizing combination, is used for disorders of keratinization and superficial skin lesions.

• Acne vulgaris: reduces lesions and inflammation by promoting exfoliation of clogged pores.
• Plaque psoriasis: softens plaques and decreases scaling through keratolysis.
• Callus/Keratoderma: helps exfoliate thickened skin, improving texture and comfort.

• Salicylic acid acts as a keratolytic by disrupting intercellular cohesion within the stratum corneum, facilitating desquamation of hyperkeratotic tissue. The mucopolysaccharide polysulfuric acid ester component contributes moisturizing and mild exfoliating properties, enhancing skin barrier hydration while supporting the keratolytic action of salicylic acid.

Common Side Effects

• Skin irritation: mild redness or discomfort at the application site.
• Dryness: increased transepidermal water loss leading to flaky skin.
• Peeling: visible shedding of superficial skin layers.
• Itching: transient pruritus during the exfoliation process.
• Burning sensation: brief warmth or tingling after application.
• Contact dermatitis: localized allergic reaction in sensitive individuals.

Serious or Rare Side Effects

• Severe allergic contact dermatitis: extensive rash, swelling, or blistering.
• Skin ulceration: deep tissue breakdown with prolonged use.
• Systemic salicylate toxicity: rare, may present with tinnitus or nausea if large areas are covered.
• Photosensitivity: heightened reaction to sunlight causing erythema.
• Erythema multiforme: target‑like lesions requiring medical attention.
• Anaphylaxis: life‑threatening systemic allergic response, though extremely uncommon.

Precautions for using Movelat Relief include:

• Avoid application on broken or inflamed skin: may increase irritation.
• Do not use on large surface areas: limits systemic absorption.
• Keep away from eyes and mucous membranes: can cause severe irritation.
• Use with caution in patients with known salicylate allergy: risk of hypersensitivity.
• Not recommended for children under 2 years of age unless directed by a clinician.
• Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Potential drug interactions for Movelat Relief are:

Major Interactions (Avoid)

• Concurrent use with other topical keratolytics (e.g., high‑strength benzoyl peroxide): may cause excessive irritation.
• Systemic salicylates (e.g., aspirin): can increase overall salicylate exposure.
• Occlusive dressings over the treated area: enhances absorption and risk of toxicity.
• Combination with retinoids: may lead to severe skin irritation.
• Use with photosensitizing agents: heightens risk of phototoxic reactions.

Moderate Interactions (Monitor Closely)

• Co‑application with moisturizers: may reduce irritation but monitor for reduced efficacy.
• Use with topical antibiotics: can lower infection risk, watch for allergic reactions.
• Combination with topical corticosteroids: may mitigate irritation, assess skin response.
• Concurrent acne therapies (e.g., clindamycin): monitor for cumulative irritation.
• Use with wound‑healing agents: ensure no interference with exfoliation process.